Jessica Tassan
Stock Analyst at Piper Sandler
(1.08)
# 3,732
Out of 4,534 analysts
221
Total ratings
45.5%
Success rate
-0.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintained: Buy | $420 → $475 | $421.55 | +12.68% | 20 | Jul 15, 2026 | |
| CTEV Claritev | Maintained: Buy | $90 → $61 | $30.12 | +102.52% | 10 | Jun 3, 2026 | |
| PHR Phreesia | Downgraded: Hold | $34 → $12 | $10.68 | +12.36% | 16 | May 28, 2026 | |
| DOCS Doximity | Reiterated: Buy | $42 | $21.73 | +93.28% | 13 | May 14, 2026 | |
| HUM Humana | Maintained: Hold | $272 → $254 | $398.20 | -36.21% | 7 | May 13, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | $4 → $2 | $2.16 | -7.41% | 17 | May 12, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $36 | $26.26 | +37.09% | 11 | May 8, 2026 | |
| HNGE Hinge Health | Maintained: Buy | $60 → $95 | $87.70 | +8.32% | 6 | May 6, 2026 | |
| CVS CVS Health | Rated: Buy | $101 → $99 | $107.61 | -8.00% | 11 | Mar 31, 2026 | |
| CI The Cigna Group | Reiterated: Buy | $374 → $370 | $283.94 | +30.31% | 6 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $21.10 | +42.18% | 14 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $9 | $9.65 | -6.74% | 22 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $45.22 | +8.36% | 21 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $13 → $25 | $29.60 | -15.54% | 8 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $5.93 | +203.54% | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $8 | $12.58 | n/a | 13 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $10 | $4.80 | n/a | 4 | Jan 17, 2024 |
UnitedHealth Group
Jul 15, 2026
Maintained: Buy
Price Target: $420 → $475
Current: $421.55
Upside: +12.68%
Claritev
Jun 3, 2026
Maintained: Buy
Price Target: $90 → $61
Current: $30.12
Upside: +102.52%
Phreesia
May 28, 2026
Downgraded: Hold
Price Target: $34 → $12
Current: $10.68
Upside: +12.36%
Doximity
May 14, 2026
Reiterated: Buy
Price Target: $42
Current: $21.73
Upside: +93.28%
Humana
May 13, 2026
Maintained: Hold
Price Target: $272 → $254
Current: $398.20
Upside: -36.21%
Health Catalyst
May 12, 2026
Reiterated: Hold
Price Target: $4 → $2
Current: $2.16
Upside: -7.41%
Privia Health Group
May 8, 2026
Reiterated: Buy
Price Target: $36
Current: $26.26
Upside: +37.09%
Hinge Health
May 6, 2026
Maintained: Buy
Price Target: $60 → $95
Current: $87.70
Upside: +8.32%
CVS Health
Mar 31, 2026
Rated: Buy
Price Target: $101 → $99
Current: $107.61
Upside: -8.00%
The Cigna Group
Mar 3, 2026
Reiterated: Buy
Price Target: $374 → $370
Current: $283.94
Upside: +30.31%
Mar 2, 2026
Reiterated: Buy
Price Target: $30
Current: $21.10
Upside: +42.18%
Feb 26, 2026
Reiterated: Buy
Price Target: $12 → $9
Current: $9.65
Upside: -6.74%
Feb 23, 2026
Reiterated: Buy
Price Target: $49
Current: $45.22
Upside: +8.36%
Nov 26, 2025
Upgraded: Buy
Price Target: $13 → $25
Current: $29.60
Upside: -15.54%
Sep 5, 2025
Reiterated: Buy
Price Target: $18
Current: $5.93
Upside: +203.54%
May 23, 2025
Reiterated: Hold
Price Target: $10 → $8
Current: $12.58
Upside: n/a
Jan 17, 2024
Maintained: Hold
Price Target: $13 → $10
Current: $4.80
Upside: n/a